Aduro Biotech Announces Immunotherapy Regimen Successfully Passes Futility Analysis in Phase 2b ECLIPSE Trial in Metastatic Pancreatic Cancer

(Source: GlobeNewswire ) .. Arm B patients receiving GVAX monotherapy (HR=0.5930, one-sided p=0.0172). … of technology platforms to stimulate an immune response against cancer.